---
title: "Independent Clinical Data Assessments: What's Expected | CluePoints"
description: Learn a regulatory perspective on what is expected from an independent and objective assessment of clinical data.
---

# WEBINAR RECORDING

### A REGULATORY PERSPECTIVE ON WHAT'S EXPECTED FROM AN INDEPENDENT ASSESSMENT OF CLINICAL DATA

## What's Covered in this Webinar?

This webinar recording provides a regulatory perspective on what is expected from an independent and objective assessment of clinical data.  
Discussion points include;

- What the FDA and EMA are encouraging Sponsors to look at as part of their assessment of data quality.
- Identifying the different types of data analysis required to de-risk studies
- A review of case studies that exemplify a powerful approach to data management

Got a question? Give us a call on 0032 10 77 89 10, or send us an email to [contact@cluepoints.com](mailto:contact@cluepoints.com) 

 

### First Pain Point

This should be the biggest pain your clients have as it relates to your service. What are you doing for them?

[Read More](https://www.webcanopystudio.com)

### First Pain Point

This should be the biggest pain your clients have as it relates to your service. What are you doing for them?

[Read More](https://www.webcanopystudio.com)

### First Pain Point

This should be the biggest pain your clients have as it relates to your service. What are you doing for them?

[Read More](https://www.webcanopystudio.com)

![prelude2logo-dark](https://cdn2.hubspot.net/hub/395201/hubfs/Prelude%202.0/prelude2logo-dark.png?width=3942&name=prelude2logo-dark.png "prelude2logo-dark")

© 2026 CluePoints Inc.